After sampling and fabricating of TMAs, we stained a total number of 21 TMAs comprising 1,859 breast cancer samples with the glycan-binding receptors CD301, Langerin, LSECtin and DC-SIGNR, respectively (Fig. 2B). This evidence concerns the gene CLEC10A and breast carcinoma.